ROBAXISAL
Live / Allowed — Notice of allowance issued (as of 03 Mar 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 04 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99066419
- Mark type
- Stylized text
- Filed
- 04 Mar 2025
- Published for opposition
- 06 Jan 2026
- Attorney of record
- Stephen A. Seach, Jr.
Goods and services
- Class 005 — Pharmaceuticals: Prescription analgesic pharmaceutical preparations containing methocarbamol and acetylsalicylic acid as active ingredients, in the form of a multi-layered tablet for oral use
Owner
- Oliva Therapeutics, LLC, Ridgewood, NJ, US
- Oliva Therapeutics, LLC, Ridgewood, NJ, US
Prosecution history
- 03 Mar 2026 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 06 Jan 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 06 Jan 2026 — PUBLISHED FOR OPPOSITION
- 31 Dec 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Dec 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 09 Dec 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 09 Dec 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 09 Dec 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 08 Dec 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 08 Dec 2025 — NON-FINAL ACTION E-MAILED
- 08 Dec 2025 — NON-FINAL ACTION WRITTEN
- 10 Nov 2025 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 10 Nov 2025 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 10 Nov 2025 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 11 Aug 2025 — NOTIFICATION OF NON-FINAL ACTION E-MAILED